Hendricks R L, Tumpey T M, Finnegan A
Department of Ophthalmology and Visual Sciences, University of Illinois, Chicago 60612.
J Immunol. 1992 Nov 1;149(9):3023-8.
HSV type 1 (HSV-1) infection of the mouse cornea results in a tissue-destructive inflammatory reaction in the cornea, but little or no disease in the skin surrounding the eye. Depleting T lymphocytes from mice before HSV-1 corneal infection prevents the corneal inflammation but severely exacerbates the periocular skin lesions. Studies described in this communication investigated the role of T cell cytokines in the corneal and periocular skin disease induced by HSV-1 corneal infection. Mice received weekly i.p. injections of rat mAb specific for IL-2, IL-4, or IFN-gamma beginning 1 day before (day -1) or 6 days after (day +6) corneal infection with the RE strain of HSV-1. The severity of corneal inflammation and the area of periocular skin involvement were measured. Treatment with anti-IFN-gamma or anti-IL-2 significantly reduced the incidence and severity of corneal inflammation. Treatment was equally effective when initiated on day -1 (before T cell activation) or day +6 (after T cell activation but before the initiation of corneal inflammation). Treatment with anti-IL-4 had no effect. The histologic features of corneal inflammation in mock-treated mice included neovascularization, corneal edema, and cellular infiltration. Corneas of anti-IL-2-treated mice that developed inflammation had similar but less severe histologic features. Corneas of anti-IFN-gamma-treated mice that developed inflammation had neovascularization and edema but minimal cellular infiltration. Treatment with anti-IFN-gamma or anti-IL-2 significantly exacerbated periocular skin lesions when initiated at day -1, but not when initiated at day +6. Anti-IL-4 treatment had no effect on skin lesions. Treatment with either anti-IFN-gamma or anti-IL-2, when initiated at day -1, significantly inhibited the delayed-type hypersensitivity response to HSV Ag, but when treatment was begun at day +6 only anti-IFN-gamma significantly inhibited the delayed-type hypersensitivity response. Our findings suggest that IFN-gamma and IL-2 are important elements in both an immunopathologic T-lymphocyte response to HSV-1 Ag in the cornea and a protective T lymphocyte response in the skin.
单纯疱疹病毒1型(HSV-1)感染小鼠角膜会导致角膜组织破坏性炎症反应,但眼部周围皮肤几乎不发病或无病变。在HSV-1角膜感染前清除小鼠体内的T淋巴细胞可预防角膜炎症,但会严重加剧眼周皮肤病变。本通讯中描述的研究调查了T细胞细胞因子在HSV-1角膜感染诱发的角膜和眼周皮肤疾病中的作用。从角膜感染HSV-1 RE株前1天(-1天)或感染后6天(+6天)开始,小鼠每周腹腔注射一次针对IL-2、IL-4或IFN-γ的大鼠单克隆抗体。测量角膜炎症的严重程度和眼周皮肤受累面积。用抗IFN-γ或抗IL-2治疗可显著降低角膜炎症的发生率和严重程度。在-1天(T细胞激活前)或+6天(T细胞激活后但角膜炎症开始前)开始治疗,效果相同。用抗IL-4治疗无效。未处理小鼠角膜炎症的组织学特征包括新生血管形成、角膜水肿和细胞浸润。发生炎症的抗IL-2治疗小鼠的角膜具有相似但不太严重的组织学特征。发生炎症的抗IFN-γ治疗小鼠的角膜有新生血管形成和水肿,但细胞浸润极少。在-1天开始用抗IFN-γ或抗IL-2治疗会显著加剧眼周皮肤病变,但在+6天开始治疗则不会。抗IL-4治疗对皮肤病变无影响。在-1天开始用抗IFN-γ或抗IL-2治疗,可显著抑制对HSV抗原的迟发型超敏反应,但在+6天开始治疗时,只有抗IFN-γ能显著抑制迟发型超敏反应。我们的研究结果表明,IFN-γ和IL-2在角膜中对HSV-1抗原的免疫病理T淋巴细胞反应以及皮肤中的保护性T淋巴细胞反应中都是重要因素。